Author:
Huang Xingjie,Wen Song,Huang Yuqing,Huang Zehan
Abstract
Abstract
Objective
The relationship between changes in Atherogenic Index of Plasma (AIP) and cardiometabolic diseases (CMD) in middle-aged and elderly individuals remains unclear. This study aims to explore the association between changes in AIP and CMD.
Methods
This study included 3,791 individuals aged over 45 years from CHARLS. Participants were divided into four groups using the K-Means clustering method. Cumulative AIP was used as a quantitative indicator reflecting changes in AIP. Differences in baseline data and CMD incidence rates among these four groups were compared. Multifactorial logistic regression models were used to assess the relationship between changes in AIP and CMD, and subgroup analysis and interaction tests were conducted to evaluate potential relationships between changes in AIP and CMD across different subgroups. Restricted cubic splines (RCS) were used to assess the dose-response relationship between cumulative AIP and CMD.
Results
Changes in AIP were independently and positively associated with CMD. In males, the risk significantly increased in class4 compared to class1 (OR 1.75, 95%CI 1.12-2.73). In females, changes in AIP were not significantly associated with CMD. Cumulative AIP was positively correlated with CMD (OR 1.15, 95%CI 1.01-1.30), with significant gender differences in males (OR 1.29, 95%CI 1.07-1.55) and females (OR 1.03, 95%CI 0.87-1.23) (p for interaction = 0.042). In addition, a linear relationship was observed between cumulative AIP and CMD in male.
Conclusion
Substantial changes in AIP may increase the risk of CMD in middle-aged and elderly Chinese males. Dynamic monitoring of AIP is of significant importance for the prevention and treatment of CMD.
Funder
Guangxi Natural Science Foundation
Guangxi Medical and Healthcare Appropriate Technology Development and Popularization and Application Project
Guangxi Clinical Key Specialty Construction Project
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Koshiyama H, Taniguchi A, Inagaki N, Seino Y. Is the concept of “cardiometabolic risk” more useful than “metabolic syndrome”? Diabetic Med. 2007;24(5):571.
2. Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition–multimorbidity. Jama-J Am Med ASSOC. 2012;307(23):2493–4.
3. Sattar N, Gill J, Alazawi W. Improving prevention strategies for cardiometabolic disease. NAT MED. 2020;26(3):320–5.
4. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396(10258):1204-1222.
5. Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. LANCET. 2019;394(10204):1145–58.